Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990795 · ClinicalTrials.gov registry record · Phase 1
Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT00990795 is a Phase 1 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 72 participants.
The verdict
NCT00990795, a Phase 1 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
Administration of cyclosporine has been found to have a myocardial protective effect, improving post-operative cardiac function in patients undergoing percutaneous coronary interventions by diminishing infarct size. The purpose of the proposed study is to conduct a randomized, controlled clinical trial in patients undergoing isolated valvular heart surgery, or coronary artery bypass surgery. Specifically the investigators will evaluate the cardio-protective effects of cyclosporine on post ischemic-arrest myocardium. The two factors will be treatment group and cyclosporine versus placebo.
Interventions
- DRUG saline solution
- DRUG cyclosporine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00990795
The ClinicalTrials.gov registry entry for NCT00990795 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline solution is the first listed.
NCT00990795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00990795 about?
NCT00990795 is a clinical study titled "Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery". Administration of cyclosporine has been found to have a myocardial protective effect, improving post-operative cardiac function in patients undergoing percutaneous coronary interventions by diminishing infarct size. The purpose of the proposed study is to conduct a randomized, controlled clinical tr...
What is the current status of trial NCT00990795?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2010-04. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00990795?
The interventions under investigation include: saline solution (DRUG), cyclosporine (DRUG).
Who is sponsoring clinical trial NCT00990795?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.